(VIANEWS) - Mesabi Trust (MSB), Pzena Investment Management (PZN), Oxford Lane Capital Corp. (OXLCP) have the highest dividend yield stocks on this list.
| Rank | Financial Asset | Price | Change | Forward Dividend Yield | Updated (EST) |
|---|---|---|---|---|---|
| 1 | Mesabi Trust (MSB) | 28.50 | 1.79% | 14.56% | 2022-04-15 09:06:06 |
| 2 | Pzena Investment Management (PZN) | 7.27 | -2.15% | 8.34% | 2022-04-16 03:46:07 |
| 3 | Oxford Lane Capital Corp. (OXLCP) | 24.74 | -0.4% | 6.29% | 2022-04-04 09:12:06 |
| 4 | Cohen & Steers Total Return Realty Fund (RFI) | 15.57 | -0.95% | 6.07% | 2022-04-16 05:08:06 |
| 5 | Bristol (BMY) | 76.22 | -0.68% | 3.2% | 2022-04-19 09:07:17 |
A little less 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. Mesabi Trust (MSB) - Dividend Yield: 14.56%
Mesabi Trust is a trust that pays royalty to those who are involved in iron ore mining in the United States. It was established in New York in 1961.
Volume
Today's last reported volume for Mesabi Trust is 75807, 43.35% below its average volume of 133816.
Mesabi Trust's last close was $28.50, 28.05% below its 52-week high of $39.61.
Mesabi Trust's Revenue
Year-on-year quarterly revenue growth grew by 284.4%, now sitting on 53.71M for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,Mesabi Trust's stock is considered to be oversold (<=20).
Mesabi Trust's Stock Yearly Top and Bottom Value
Mesabi Trust's stock is valued at $28.50 at 10:15 EST, way under its 52-week high of $39.61 and way above its 52-week low of $20.02.
Mesabi Trust's Moving Average
Mesabi Trust's worth is above its 50-day moving average of $26.53 and under its 200-day moving average of $29.32.More news about Mesabi Trust.
2. Pzena Investment Management (PZN) - Dividend Yield: 8.34%
Pzena Investment Management, Inc., is an investment manager that is publicly held. It manages equity mutual funds on behalf of its clients. The firm invests in public equity markets. Pzena Investment Management, Inc., was established in 2007. It is located in New York City and has additional offices in Melbourne, Australia, and London, United Kingdom.
Volume
Today's last reported volume for Pzena Investment Management is 113021, 23.89% above its average volume of 91224.
Pzena Investment Management's last close was $7.27, 40.07% under its 52-week high of $12.13.
Pzena Investment Management's Revenue
Year-on-year quarterly revenue growth grew by 27.9%, now sitting on 199.33M for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,Pzena Investment Management's stock is considered to be overbought (>=80).
Pzena Investment Management's Stock Yearly Top and Bottom Value
Pzena Investment Management's stock is valued at $7.27 at 10:15 EST, way below its 52-week high of $12.13 and higher than its 52-week low of $7.20.
Pzena Investment Management's Moving Average
Pzena Investment Management's value is way under its 50-day moving average of $8.56 and way below its 200-day moving average of $9.96.More news about Pzena Investment Management.
3. Oxford Lane Capital Corp. (OXLCP) - Dividend Yield: 6.29%
Oxford Lane Capital Corp. was launched by Oxford Lane Management LLC and is managed by Oxford Lane Management LLC. The fund invests in fixed-income securities. It invests mainly in securitization instruments, which then invest in senior secured loan made to unrated or below-investment grade companies. Oxford Lane Capital Corp was established on June 9, 2010, and it is based in the United States.
Volume
Today's last reported volume for Oxford Lane Capital Corp. is 252, 96.04% below its average volume of 6359.
Oxford Lane Capital Corp.'s last close was $24.71, 3.85% below its 52-week high of $25.70.
Oxford Lane Capital Corp.'s Revenue
Year-on-year quarterly revenue growth grew by 45.3%, now sitting on 154.44M for the twelve trailing months.
Oxford Lane Capital Corp.'s Stock Yearly Top and Bottom Value
Oxford Lane Capital Corp.'s stock is valued at $24.74 at 10:15 EST, under its 52-week high of $25.70 and above its 52-week low of $22.63.
Oxford Lane Capital Corp.'s Moving Average
Oxford Lane Capital Corp.'s value is below its 50-day moving average of $25.00 and below its 200-day moving average of $25.16.More news about Oxford Lane Capital Corp..
4. Cohen & Steers Total Return Realty Fund (RFI) - Dividend Yield: 6.07%
Cohen & Steers Total Return Realty Fund, Inc., is a closed-ended equity mutual funds that was launched by Cohen & Steers, Inc. Cohen & Steers Capital Management, Inc. manages the fund. The fund invests in American public equity markets. It invests in stock of real estate companies, as well as real estate investment trusts. The fund invests in stock of all companies, regardless of their market capitalization. The portfolio's performance is compared to the FTSE NAREIT Equity REIT Index or the S&P 500 Index. A blended index of 80% FTSE NAREIT Equity REIT Index & 20% BofA Merrill Lynch REIT Preferred Securities Index provides a benchmark. Cohen & Steers Total Return Realty Fund, Inc., was established on September 4, 1992. It is based in the United States.
Volume
Today's last reported volume for Cohen & Steers Total Return Realty Fund is 47372, 15.86% below its average volume of 56303.
Cohen & Steers Total Return Realty Fund's last close was $15.57, 13.6% below its 52-week high of $18.02.
Cohen & Steers Total Return Realty Fund's Revenue
Year-on-year quarterly revenue growth declined by 14.5%, now sitting on 8.15M for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,Cohen & Steers Total Return Realty Fund's stock is considered to be overbought (>=80).
Cohen & Steers Total Return Realty Fund's Stock Yearly Top and Bottom Value
Cohen & Steers Total Return Realty Fund's stock is valued at $15.57 at 10:15 EST, way below its 52-week high of $18.02 and way above its 52-week low of $14.15.
Cohen & Steers Total Return Realty Fund's Moving Average
Cohen & Steers Total Return Realty Fund's worth is higher than its 50-day moving average of $15.41 and below its 200-day moving average of $16.28.More news about Cohen & Steers Total Return Realty Fund.
5. Bristol (BMY) - Dividend Yield: 3.2%
The Bristol-Myers Squibb Company develops and licenses products for biopharmaceutical use. It markets, distributes, sells, and markets them worldwide. The company offers therapeutic products in the following therapeutic categories: oncology and immunology, hematology, cardiology, vascular, and hematology. Opdivo is a biologic product that can be used to treat anti-cancer indications. Eliquis, which targets stroke prevention in adults with non-valvular arrial fibrillation and prevention and treatment venous thromboembolic diseases, and Orencia for active RA patients and pediatric patients suffering from active juvenile idiopathic arthritis, are other products. Sprycel is a tyrosine kinase inhibitor for treatment Philadelphia chromosome positive chronic myeloidleukemia. Yervoy is a monoclonal anti-cancer antibody that can be used to treat patients with metastatic or unresectable melanoma. Empliciti, a humanized monoclonal antibodies for treatment of multiple myeloma, and Baraclude is an oral antiviral drug for chronic hepatitis B. It also offers Reyataz as a protease inhibit for treatment of the human immunodeficiencyvirus (HIV); Sustiva, a non nucleoside reverse transcriptase inhibitor for treatment of HIV; Daklinza NS5A replica complex inhibitor, Sunvepra NS3 protease inhibitor and Beclabuvir NS5B antagonist. The company sells its products to hospitals, wholesalers and retail pharmacies as well as the medical profession. Pfizer, Otsuka, Nektar, GRYT Health, Ubiquigent Limited, NeoImmuneTech, Inc., and Astrazeneca Plc are some of the company's collaboration partners. The original name of the company was Bristol-Myers Company. In 1989, it changed its name from Bristol-Myers Squibb Company to Bristol-Myers Squibb Company. Bristol-Myers Squibb Company is located in New York, New York. It was established in 1887.
Volume
Today's last reported volume for Bristol is 1458680, 90.46% below its average volume of 15293800.
Bristol's last close was $76.75, 10.04% higher than its 52-week high of $69.75.
Bristol's Sales
Bristol's sales growth is 12.5% for the current quarter and 9.4% for the next. The company's growth estimates for the ongoing quarter and the next is 19% and 27.4%, respectively.
Bristol's Revenue
Year-on-year quarterly revenue growth grew by 15.5%, now sitting on 44.38B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,Bristol's stock is considered to be oversold (<=20).
Bristol's Stock Yearly Top and Bottom Value
Bristol's stock is valued at $76.22 at 10:16 EST, above its 52-week high of $69.75.
Bristol's Moving Average
Bristol's value is way higher than its 50-day moving average of $57.79 and way higher than its 200-day moving average of $63.26.Previous days news about Bristol
- Nektar, bristol myers squibb end clinical development of combination therapy including opdivo. According to MarketWatch on Monday, 18 April, "Shares of Nektar Therapeutics Inc. were down 35.9% in trading on Monday after the company announced Friday that it halted development of bempegaldesleukin in combination with Bristol Myers Squibb's Opdivo. "
More news about Bristol.